Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial
- 16 March 2002
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 359 (9310), 920-925
- https://doi.org/10.1016/s0140-6736(02)08022-4
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis: Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR)Journal of the American College of Cardiology, 2000
- Relation Between Hospital Primary Angioplasty Volume and Mortality for Patients With Acute MI Treated With Primary Angioplasty vs Thrombolytic TherapyJAMA, 2000
- Reperfusion revisited: Beyond TIMI3 flowClinical Cardiology, 1999
- Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarctionThe American Journal of Cardiology, 1998
- Clinical Experience With Primary Percutaneous Transluminal Coronary Angioplasty Compared With Alteplase (Recombinant Tissue-Type Plasminogen Activator) in Patients With Acute Myocardial Infarction : A Report From the Second National Registry of Myocardial Infarction (NRMI-2)Journal of the American College of Cardiology, 1998
- Comparison of Primary Coronary Angioplasty and Intravenous Thrombolytic Therapy for Acute Myocardial InfarctionJAMA, 1997
- A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial InfarctionThe New England Journal of Medicine, 1996
- Platelet Function in Acute Myocardial Infarction Treated With Direct AngioplastyCirculation, 1996
- Cardiac Release of Cytokines and Inflammatory Responses in Acute Myocardial InfarctionCirculation, 1995
- Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?Circulation, 1989